chr14-24238317-G-A
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4
The NM_001002002.3(GMPR2):c.769G>A(p.Glu257Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000173 in 1,614,002 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001002002.3 missense
Scores
Clinical Significance
Conservation
Publications
- dyskeratosis congenita, autosomal dominant 3Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- Revesz syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, PanelApp Australia, Orphanet
- pulmonary fibrosisInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- dyskeratosis congenitaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Hoyeraal-Hreidarsson syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- thyroid gland papillary carcinomaInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152136Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000401 AC: 10AN: 249578 AF XY: 0.0000369 show subpopulations
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1461866Hom.: 0 Cov.: 32 AF XY: 0.0000179 AC XY: 13AN XY: 727236 show subpopulations
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152136Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74318 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.823G>A (p.E275K) alteration is located in exon 8 (coding exon 8) of the GMPR2 gene. This alteration results from a G to A substitution at nucleotide position 823, causing the glutamic acid (E) at amino acid position 275 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at